Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

1/8/25 4:15:00 PM ET

Medical Specialities

Health Care

Get the next $LH alert in real time by email

BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2024 before the market opens on Thursday, February 6, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.

A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until January 24, 2026. To access the webcast recording, visit the Labcorp Investor Relations website.

About Labcorp

Labcorp (NYSE:LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-announce-fourth-quarter-financial-results-on-february-6-2025-302346207.html

SOURCE Labcorp

Get the next $LH alert in real time by email

Recent Analyst Ratings for

$LH

Date	Price Target	Rating	Analyst
7/10/2025	$260.00	Buy → Hold	HSBC Securities
4/2/2025	$276.00	Buy	Redburn Atlantic
3/4/2025	$250.00 → $300.00	Neutral → Buy	Citigroup
1/7/2025	$260.00 → $265.00	In-line → Outperform	Evercore ISI
12/10/2024	$265.00 → $275.00	Buy	Jefferies
10/30/2024		Hold → Buy	HSBC Securities
10/1/2024	$235.00	Neutral	Piper Sandler
3/25/2024	$250.00	Hold → Buy	Argus

More analyst ratings

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

1/8/25 4:15:00 PM ET

$LH

Medical Specialities

Health Care

Get the next $LH alert in real time by email

View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-announce-fourth-quarter-financial-results-on-february-6-2025-302346207.html

SOURCE Labcorp

Get the next $LH alert in real time by email

Recent Analyst Ratings for

$LH

Date	Price Target	Rating	Analyst
7/10/2025	$260.00	Buy → Hold	HSBC Securities
4/2/2025	$276.00	Buy	Redburn Atlantic
3/4/2025	$250.00 → $300.00	Neutral → Buy	Citigroup
1/7/2025	$260.00 → $265.00	In-line → Outperform	Evercore ISI
12/10/2024	$265.00 → $275.00	Buy	Jefferies
10/30/2024		Hold → Buy	HSBC Securities
10/1/2024	$235.00	Neutral	Piper Sandler
3/25/2024	$250.00	Hold → Buy	Argus

More analyst ratings

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$LH

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$LH

$LH
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Anderson Kerrii B sold $132,500 worth of shares (500 units at $265.00), decreasing direct ownership by 4% to 12,166 units (SEC Form 4)

Director Anderson Kerrii B sold $130,000 worth of shares (500 units at $260.00), decreasing direct ownership by 4% to 12,666 units (SEC Form 4)

EVP, Pres of ED, CMO & CSO Caveney Brian J sold $494,000 worth of shares (2,000 units at $247.00), decreasing direct ownership by 6% to 30,067 units (SEC Form 4)

$LH
Press Releases

Fastest customizable press release news feed in the world

Labcorp Declares Quarterly Dividend

Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

$LH
SEC Filings

Labcorp Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Labcorp Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

Labcorp Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

$LH
Leadership Updates

Live Leadership Updates

Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors

SOLVD Health Appoints Mike Aicher and Vince Cebula to Board of Directors to Support Next Phase of Growth

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

$LH
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Laboratory Corporation of America Holdings (Amendment)

SEC Form SC 13D/A filed by Laboratory Corporation of America Holdings (Amendment)

SEC Form SC 13G/A filed

$LH
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Labcorp Holdings Inc. downgraded by HSBC Securities with a new price target

Redburn Atlantic initiated coverage on Labcorp Holdings Inc. with a new price target

Labcorp Holdings Inc. upgraded by Citigroup with a new price target

$LH
Financials

Live finance-specific insights

Labcorp Declares Quarterly Dividend

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

Labcorp Announces 2025 First Quarter Results

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $LH

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $LH

$LH Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Anderson Kerrii B sold $132,500 worth of shares (500 units at $265.00), decreasing direct ownership by 4% to 12,166 units (SEC Form 4)

Director Anderson Kerrii B sold $130,000 worth of shares (500 units at $260.00), decreasing direct ownership by 4% to 12,666 units (SEC Form 4)

EVP, Pres of ED, CMO & CSO Caveney Brian J sold $494,000 worth of shares (2,000 units at $247.00), decreasing direct ownership by 6% to 30,067 units (SEC Form 4)

$LH Press Releases

Fastest customizable press release news feed in the world

Labcorp Declares Quarterly Dividend

Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

$LH SEC Filings

Labcorp Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Labcorp Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

Labcorp Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

$LH Leadership Updates

Live Leadership Updates

Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors

SOLVD Health Appoints Mike Aicher and Vince Cebula to Board of Directors to Support Next Phase of Growth

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

$LH Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Laboratory Corporation of America Holdings (Amendment)

SEC Form SC 13D/A filed by Laboratory Corporation of America Holdings (Amendment)

SEC Form SC 13G/A filed

$LH Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Labcorp Holdings Inc. downgraded by HSBC Securities with a new price target

Redburn Atlantic initiated coverage on Labcorp Holdings Inc. with a new price target

Labcorp Holdings Inc. upgraded by Citigroup with a new price target

$LH Financials

Live finance-specific insights

Labcorp Declares Quarterly Dividend

Labcorp to Announce Second Quarter Financial Results on July 24, 2025

Labcorp Announces 2025 First Quarter Results

Recent Analyst Ratings for
$LH

Recent Analyst Ratings for
$LH

$LH
Insider Trading

$LH
Press Releases

$LH
SEC Filings

$LH
Leadership Updates

$LH
Large Ownership Changes

$LH
Analyst Ratings

$LH
Financials